Paul Ryan expressed confidence that the Republican health-care plan will pass the House later this week, saying his party’s lawmakers are working to make changes to the bill to address remaining concerns, including providing more assistance to older Americans.
A Canadian research team found low doses of the blood thinner rivaroxaban, marketed as Xarelto from Johnson & Johnson unit Janssen Pharmaceuticals, reduced the risk of blood clot recurrence by about 70% compared with aspirin, without increasing the risk of bleeding.
Republican senators, alarmed by a nonpartisan report showing millions would lose insurance under the GOP health-care plan, warned Tuesday that the bill wouldn’t become law without fundamental changes.
FDA chief nominee Scott Gottlieb’s changes may pressure generic drug prices, but there are other positives for the sector.
A federal analysis of a Republican health plan that shows it would leave millions more uninsured has a silver lining for GOP leaders: In general, premiums under their proposal would eventually come down for younger people.
The benefits of an opioid painkiller linked to a 2015 HIV outbreak in Indiana no longer outweigh the risks, a panel of advisers to the U.S. Food and Drug Administration concluded Tuesday.
Democrats, after playing defense on health care for nearly a decade, are trying to turn the issue to their advantage in next year’s midterm elections, targeting in particular lawmakers who have already voted for the GOP health bill.
The number of Americans without health insurance would grow by 24 million under a House Republican proposal to topple most of the Affordable Care Act, according to a nonpartisan report that is likely to complicate GOP lawmakers’ efforts to unite around the plan.
William Ackman’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history.
AstraZeneca is working with outside researchers to look for untapped potential in drugs that the company has shelved, part of a broader move to improve its research-and-development output.
New York City will spend $38 million annually to combat an opioid epidemic that killed more than 1,000 New Yorkers last year, city officials said Monday.
Seema Verma, President Donald Trump’s pick to oversee the Medicare and Medicaid programs, won Senate confirmation in a largely party-line vote Monday, placing an advocate of overhauling Medicaid at the program’s helm.
The House Republican effort to overhaul the Affordable Care Act could hit many rural areas particularly hard, sharply increasing the cost for some residents buying their own insurance.
Republicans in Congress scored a victory in their efforts to replace parts of the Affordable Care Act, pushing measures through two House committees. But opposition to the health overhaul remains strong.
Americans now officially drink more bottled water than soda. It’s a shift that decades ago might have seemed unthinkable—that consumers would buy a packaged version of something that was free from a tap.
President Donald Trump on Tuesday backed House Republicans’ proposal to repeal and replace the Affordable Care Act, but emerging conservative opposition threatened to derail the contentious plan.
Though they are applauding the elimination of some taxes, insurers foresee problems from the cancellation of penalties for going without health coverage.